Short Interest in Nephros, Inc. (NASDAQ:NEPH) Drops By 13.5%

Nephros, Inc. (NASDAQ:NEPH) was the target of a significant drop in short interest in the month of February. As of February 28th, there was short interest totalling 8,300 shares, a drop of 13.5% from the February 13th total of 9,600 shares. Currently, 0.1% of the company’s stock are short sold. Based on an average daily volume of 13,400 shares, the days-to-cover ratio is presently 0.6 days.

Nephros Stock Performance

NEPH stock opened at $1.49 on Thursday. The stock has a market cap of $15.71 million, a P/E ratio of -16.56 and a beta of 1.19. The firm has a 50 day simple moving average of $1.56 and a 200 day simple moving average of $1.58. Nephros has a 52 week low of $1.36 and a 52 week high of $2.55.

Institutional Trading of Nephros

A hedge fund recently bought a new stake in Nephros stock. Topline Capital Management LLC bought a new stake in Nephros, Inc. (NASDAQ:NEPH) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 419,887 shares of the company’s stock, valued at approximately $617,000. Topline Capital Management LLC owned about 3.98% of Nephros as of its most recent SEC filing. 41.10% of the stock is owned by institutional investors.

About Nephros

Nephros, Inc, a commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities.